Total Payments
$777.96
2024 Payments
$237.20
Companies
9
Transactions
24
Medicare Patients
5,467
Medicare Billing
$3.7M
Payment Breakdown by Category
Food & Beverage$777.96 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $777.96 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE HEALTHCARE | $227.29 | 6 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $214.61 | 4 | $0 (2024) |
| GENZYME CORPORATION | $90.53 | 1 | $0 (2017) |
| Life Molecular Imaging Ltd | $80.55 | 4 | $0 (2024) |
| Lilly USA, LLC | $69.05 | 4 | $0 (2017) |
| Telix Pharmaceuticals | $38.34 | 2 | $0 (2024) |
| Blue Earth Diagnostics Limited | $25.52 | 1 | $0 (2021) |
| Piramal Imaging Limited | $17.50 | 1 | $0 (2018) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.57 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.20 | 9 | GE HEALTHCARE ($113.91) |
| 2023 | $155.21 | 3 | Progenics Pharmaceuticals, Inc. ($89.17) |
| 2022 | $90.46 | 1 | Progenics Pharmaceuticals, Inc. ($90.46) |
| 2021 | $53.38 | 3 | Blue Earth Diagnostics Limited ($25.52) |
| 2019 | $64.63 | 2 | GE HEALTHCARE ($64.63) |
| 2018 | $17.50 | 1 | Piramal Imaging Limited ($17.50) |
| 2017 | $159.58 | 5 | GENZYME CORPORATION ($90.53) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $9.16 | General |
| Category: Diagnostic Tracer | ||||||
| 10/11/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/04/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $32.00 | General |
| 08/06/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $26.48 | General |
| Category: Diagnostic Tracer | ||||||
| 07/29/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/19/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/08/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $33.15 | General |
| 02/28/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $31.62 | General |
| Category: Diagnostic Tracer | ||||||
| 02/14/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $48.76 | General |
| 12/06/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $48.75 | General |
| 06/13/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 03/02/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $89.17 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/30/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $90.46 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/27/2021 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: Diagnostic Tracer | ||||||
| 08/10/2021 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Diagnostic Imaging | ||||||
| 02/23/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $34.77 | General |
| 04/23/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $29.86 | General |
| 02/21/2018 | Piramal Imaging Limited | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Diagnostic Tracer | ||||||
| 10/11/2017 | GENZYME CORPORATION | THYROGEN (Drug) | Food and Beverage | In-kind items and services | $90.53 | General |
| Category: RARE DISEASE METABOLIC | ||||||
| 09/06/2017 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Neuroscience | ||||||
| 06/09/2017 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Neuroscience | ||||||
| 05/16/2017 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Neuroscience | ||||||
| 02/10/2017 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,491 | 22,565 | $3.6M | $1.2M |
| 2022 | 24 | 1,538 | 24,529 | $3.3M | $1.1M |
| 2021 | 24 | 1,361 | 25,139 | $2.7M | $869,973 |
| 2020 | 16 | 1,077 | 27,702 | $1.8M | $514,657 |
Total Patients
5,467
Total Services
99,935
Medicare Billing
$3.7M
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 225 | 244 | $1.2M | $361,616 | 29.6% |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2023 | 49 | 401 | $367,499 | $211,053 | 57.4% |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | Office | 2023 | 101 | 101 | $606,000 | $208,650 | 34.4% |
| Q9983 | Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | Office | 2023 | 27 | 27 | $135,000 | $59,270 | 43.9% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 131 | 198 | $178,200 | $55,081 | 30.9% |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | Office | 2023 | 11 | 65 | $99,400 | $50,982 | 51.3% |
| 78814 | Nuclear medicine study limited area with ct scan | Office | 2023 | 30 | 30 | $150,000 | $45,200 | 30.1% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 134 | 219 | $197,100 | $34,228 | 17.4% |
| 78830 | Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | Office | 2023 | 73 | 73 | $65,700 | $30,083 | 45.8% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 17 | 18 | $96,300 | $27,204 | 28.2% |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | Office | 2023 | 14 | 14 | $70,000 | $19,962 | 28.5% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 189 | 206 | $175,100 | $19,162 | 10.9% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Office | 2023 | 38 | 38 | $28,500 | $12,804 | 44.9% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Office | 2023 | 33 | 39 | $20,826 | $10,225 | 49.1% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 52 | 72 | $64,800 | $8,846 | 13.7% |
| 70491 | Ct scan of soft tissue of neck with contrast | Office | 2023 | 25 | 31 | $27,900 | $5,386 | 19.3% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 20 | 30 | $27,000 | $4,941 | 18.3% |
| 78999 | Other nuclear medicine study | Office | 2023 | 16 | 16 | $16,000 | $4,887 | 30.5% |
| 74160 | Ct scan of abdomen with contrast | Office | 2023 | 12 | 19 | $17,100 | $4,264 | 24.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 180 | 20,113 | $15,085 | $2,350 | 15.6% |
| A9561 | Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries | Office | 2023 | 41 | 47 | $4,700 | $1,454 | 30.9% |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | Office | 2023 | 73 | 564 | $2,820 | $91.09 | 3.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 211 | 231 | $1.1M | $354,741 | 31.0% |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2022 | 54 | 198 | $402,236 | $237,127 | 59.0% |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | Office | 2022 | 71 | 71 | $426,000 | $150,152 | 35.2% |
About Dr. Aaron Stack, M.D
Dr. Aaron Stack, M.D is a Nuclear Medicine healthcare provider based in Annandale, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821011487.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Stack, M.D has received a total of $777.96 in payments from pharmaceutical and medical device companies, with $237.20 received in 2024. These payments were reported across 24 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($777.96).
As a Medicare-enrolled provider, Stack has provided services to 5,467 Medicare beneficiaries, totaling 99,935 services with total Medicare billing of $3.7M. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Medicine
- Other Specialties Nuclear Medicine, Diagnostic Radiology
- Location Annandale, VA
- Active Since 07/25/2006
- Last Updated 08/05/2024
- Taxonomy Code 207U00000X
- Entity Type Individual
- NPI Number 1821011487
Products in Payments
- PYLARIFY (Drug) $214.61
- NEURACEQ (Drug) $98.05
- THYROGEN (Drug) $90.53
- AMYVID (Drug) $69.05
- ILLUCCIX (Drug) $38.34
- Axumin (Drug) $25.52
- LUTATHERA (Drug) $14.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.